FDLI Advertising & Promotion for Medical Products Conference
Event summary
The Advertising & Promotion for Medical Products Conference explores updated government agency initiatives, goals and priorities and trends in enforcement and regulation.
Featured agenda item
Friday, October 14, 2022 | 2:00 – 3:00 pm ETRegulatory Compliance in Advertising Digital Health Software
Cooley partner Sonia Nath spoke on the panel.
Rising use of software as a medical device (SaMD), telehealth, and other digital health software presents questions about regulatory compliance. This session provided a framework for understanding software classification and addressed new FDA guidance on clinical decision support software and mobile medical applications. Panelists examined intended use analysis and opine on the current and future state of product development and enforcement.
For more information, please email Rebecca Lanz.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.